WHO ICTRP trial
Glioblastoma broadband power as a longitudinal biomarker for tumor progression
NL-OMON54202 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON54202 |
|---|---|
| Public title | Glioblastoma broadband power as a longitudinal biomarker for tumor progression |
| Scientific title | Glioblastoma broadband power as a longitudinal biomarker for tumor progression - GOALS2 |
| Primary sponsor | Vrije Universiteit Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Countries | The Netherlands |
| Conditions | brain tumor glioblastoma;10029211;brain tumor;glioblastoma |
| Interventions | ;biomarker;brain activity;glioblastoma;glioma |
| Registration date | Feb 9, 2023 |
| Target size | 100 |
| Secondary IDs | NL76472.029.21;NL9817 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: